Literature DB >> 994000

Effect of temperature on binding of warfarin by human serum albumin.

Y T Oester, S Keresztes-Nagy, R F Mais, J Becktel, J F Zaroslinski.   

Abstract

The in vitro binding of warfarin by human serum albumin was studied at various temperatures and at pH 7.4 by a frontal gel filtration technique. The results can be best described in terms of a two class-of-binding site model, in which the numbers of primary and secondary sites are constrained to the average values for all experiments (n1 = 1.38 and n2 = 3.73). Analysis of the temperature dependence of the binding yielded the following thermodynamic parameters: deltaH1 =-2.55 kcal/mole, deltaS1=16.1 eu, and deltaF1=-7.34 kcal/mole for the primary binding and deltaH2=-5.08 kcal/mole, deltaS2=-1.10 eu, and deltaF2=4.72 kcal/mole for the secondary binding. Calculations based on these results showed that, for the therapeutic concentration range, warfarin was over 99% bound to albumin present in physiological concentration. These findings are compared and contrasted to binding data in the literature for warfarin and salicylate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 994000     DOI: 10.1002/jps.2600651127

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  Protein binding of coumarin anticoagulants in disease states.

Authors:  K Bachmann; R Shapiro
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin.

Authors:  N Rietbrock; A Lassmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

3.  Interactions of some phenylindanedione anticoagulants with human serum albumin.

Authors:  J Paubel; P Niviere; M Payard; J C Rabadeux; C P Pinazzi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

Review 4.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

5.  Interaction of Citrinin with Human Serum Albumin.

Authors:  Miklós Poór; Beáta Lemli; Mónika Bálint; Csaba Hetényi; Nikolett Sali; Tamás Kőszegi; Sándor Kunsági-Máté
Journal:  Toxins (Basel)       Date:  2015-12-01       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.